Antibody producing non-human mammals
AssigneeMerus B. V.
InventorsTon Logtenberg, Mark Throsby, Robert A. Kramer, Rui Daniel Pinto, Cornelis A. de Kruif, Erwin Houtzager
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerus B. V.
InventorsTon Logtenberg, Mark Throsby, Robert A. Kramer, Rui Daniel Pinto, Cornelis A. de Kruif, Erwin Houtzager
Estimating the term…
Described are transgenic, non-human animals comprising a nucleic acid encoding an immunoglobulin light chain, whereby the immunoglobulin light chain is human, human-like, or humanized. The nucleic acid is provided with a means that renders it resistant to DNA rearrangements and/or somatic hypermutations. In one embodiment, the nucleic acid comprises an expression cassette for the expression of a desired molecule in cells during a certain stage of development in cells developing into mature B cells. Further provided is methods for producing an immunoglobulin from the transgenic, non-human animal.
A transgenic, non-human mammal comprising, at least in its B cell lineage, a nucleic acid sequence encoding at least an immunoglobulin light chain or heavy chain, wherein the nucleic acid sequence is provided with means for rendering it resistant to DNA rearrangements and/or somatic hypermutations.
A transgenic, non-human animal which has been provided with an expression cassette for expressing a desired proteinaceous molecule in cells during a certain stage of development in cells developing into mature B cells, wherein the expression cassette comprises:
A transgenic, non-human animal that has been provided with a set of nucleic acids that are expression cassettes, wherein a first nucleic acid comprises a promoter driving expression of a cre-like protein, and the second nucleic acid comprises a sequence encoding a desired proteinaceous molecule under control of a constitutive promoter which can be activated by a cre-like protein's action.
A transgenic, non-human animal that has been provided with an expression cassette comprising, in 5′-3′ direction, a vκ promoter, a human leader, a human V gene, optionally a MoEκi enhancer, a rat constant region (κ), and, optionally, a MoEκ3′ enhancer or a truncated MoEκ3′ enhancer.
A transgenic, non-human mammal comprising:
Dependencies are inferred from the claim text.